Scaling DNA engineering
- PMID: 40441920
- PMCID: PMC12360497
- DOI: 10.1016/j.tibtech.2025.05.002
Scaling DNA engineering
Abstract
DNA can be engineered to produce new biologics, gene therapies, and cellular therapies, and to reprogram organisms. Having the ability to engineer DNA at scale can accelerate the development of these applications. Existing technologies excel at short oligonucleotide synthesis by chemical or enzymatic methods (up to 2000 bp) and intermediate-size DNA assembly (up to 5-7 kb). Yet synthesizing sequence-validated longer DNA (>10 kb) and/or constructing highly complex combinatorial DNA libraries at scale remains a significant challenge, due largely to technical and cost barriers. Inspired by recent studies on an in vivo DNA processing platform for megabase-long DNA assembly and on high-throughput sequence verification, we discuss how these platforms may be used to achieve DNA engineering at scale.
Keywords: DNA assembly; bacterial conjugation; homologous recombination.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests W.L. and S.F.L. are co-authors on patent applications based on the methods presented in this work, specifically BPS and SCRIVENER. S.F.L and G.S. co-founded BacStitch DNA Inc., to commercialize BPS and SCRIVENER. P.H.H., T.M., G.S., and S.F.L have financial interest in BacStitch DNA, Inc.
References
-
- Liao X et al. (2022) Artificial intelligence: a solution to involution of design–build–test–learn cycle. Curr. Opin. Biotechnol 75, 102712. - PubMed
-
- Beaucage SL and Caruthers MH (1981) Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett. 22, 1859–1862
-
- Stemmer WP et al. (1995) Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164, 49–53 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
